Senate committee substitute to the 3rd edition makes the following changes. 

Revises the additional authorities granted to immunizing pharmacists under GS 90-85.15B as follows. No longer includes authority for an immunizing pharmacist to order the five specified medications; maintains the authorities granted for immunizing pharmacists to dispense, deliver, or administer the five specified medications. Now includes glucagon for the treatment of severe hypoglycemia in the listed medications (previously, included glucagon or other self-administered formulations for the management of hypoglycemia). Makes conforming changes throughout the remaining proposed changes to the statute. No longer requires an immunizing pharmacist that dispenses, delivers, or administers the listed medications to provide the immunizing pharmacist's name, business address, business phone, and business fax number on any communication with a prescriber; maintains the requirement for the immunizing pharmacist to provide the business contact information of the pharmacy with any communication with a prescriber. Effective March 31, 2022, adds that an immunizing pharmacist that dispenses, delivers, or administers the listed medications must provide the name of the immunizing pharmacist who dispenses, delivers, or administers the medication on any communication with the provider. 

Adds the following required actions an immunizing pharmacist must take when administering a long-acting injectable medication pursuant to GS 90-85.15B. Requires: (1) notification of the prescriber within 48 hours of administering the medication if the injectable is in the class of psychotropic medications; and (2) notification of the prescriber if the medication prescribed in the class of psychotropic medications was not administered within 48 hours of receipt of the prescription. 

Regarding the standing order the State Health Director is directed to issue authorizing immunizing pharmacists to dispense, deliver, and administer the medications described in the act, adds that the order must include protocols for the initiation, modification, and discontinuation of each therapeutic class of medication available pursuant to the standing order.

Deems any statewide standing order issued by the State Health Director pursuant to SL 2020-3 or SL 2021-3 (regarding COVID-19 vaccine administration) to expire on December 31, 2021, unless the State Health Director determines it is necessary for the order to be extended in order to protect the public safety, health, and welfare of citizens. 

Adds to the disciplinary grounds of persons licensed to practice pharmacy or prospective licensees under GS 90-85.38 to include engaging in unprofessional conduct. Explicitly includes departing from or failing to comply with the requirements of GS 90-85.15B(c1) and (d1), when dispensing, delivering, or administering medication for patients. 

Amends GS 90-21.5 to mandate health care providers to obtain written consent from a parent or legal guardian prior to administering any vaccine that has been granted emergency use authorization and is not yet fully approved by the FDA to an individual under 18 years of age. 

Changes the act's long title.